Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion

A higher platelet-to-lymphocyte ratio (PLR) has a clinical correlation with shorter survival in non-small cell lung cancer (NSCLC). The present study evaluated the association between the PLR and survival in patients with advanced NSCLC with malignant pleural effusion (MPE). Between January 2012 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Jeong Uk, Yeo, Chang Dong, Kang, Hye Seon, Park, Chan Kwon, Kim, Ju Sang, Kim, Jin Woo, Kim, Seung Joon, Lee, Sang Haak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423003/
https://www.ncbi.nlm.nih.gov/pubmed/30886226
http://dx.doi.org/10.1038/s41598-019-41289-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423003/
https://www.ncbi.nlm.nih.gov/pubmed/30886226
http://dx.doi.org/10.1038/s41598-019-41289-9

Ejemplares similares